IOPQTL
MCID: INT323
MIFTS: 38

Intraocular Pressure Quantitative Trait Locus (IOPQTL)

Categories: Cancer diseases, Eye diseases, Neuronal diseases

Aliases & Classifications for Intraocular Pressure Quantitative Trait Locus

MalaCards integrated aliases for Intraocular Pressure Quantitative Trait Locus:

Name: Intraocular Pressure Quantitative Trait Locus 58
77 6 3 64 41 17
Iopqtl 58

Classifications:



Summaries for Intraocular Pressure Quantitative Trait Locus

PubMed Health : 64 About : Vision often worsens with age. In addition to this normal aging effect, people may also develop eye conditions that further impair their eyesight or even lead to blindness. Glaucoma is one of the more common eye diseases.The term "glaucoma" is used to describe a number of different eye conditions, all of which involve damage to the optic nerve. This leads to ever larger gaps in the field of vision, which often remain unnoticed at first. Your field of vision is what you can see when you look straight ahead, without moving your eyes. In advanced stages, your ability to see things sharply (visual acuity) also gets worse.The following information mainly covers the most common form of glaucoma, called primary open-angle glaucoma (POAG). It progresses slowly, and damage to the optic nerve will not cause vision problems for many years. Eye drops and surgery are the most common treatment options.

MalaCards based summary : Intraocular Pressure Quantitative Trait Locus is related to ritscher-schinzel syndrome and glaucoma, normal tension. An important gene associated with Intraocular Pressure Quantitative Trait Locus is ZEB1 (Zinc Finger E-Box Binding Homeobox 1), and among its related pathways/superpathways is Heart Development. Affiliated tissues include Eye, bone and eye, and related phenotypes are homeostasis/metabolism and vision/eye

Wikipedia : 77 Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss. The... more...

Description from OMIM: 611522

Related Diseases for Intraocular Pressure Quantitative Trait Locus

Diseases related to Intraocular Pressure Quantitative Trait Locus via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 35)
# Related Disease Score Top Affiliating Genes
1 ritscher-schinzel syndrome 10.1 FOXC1 OPTN
2 glaucoma, normal tension 10.1 LOXL1 OPTN
3 phacogenic glaucoma 10.0 LOXL1 OPTN
4 ocular hypertension 10.0 MYOC OPTN
5 acrofrontofacionasal dysostosis 10.0 CYP1B1 OPTN
6 vernal conjunctivitis 10.0 LOXL1 OPTN
7 uveal disease 10.0 LOXL1 OPTN
8 corneal disease 10.0 OPTN ZEB1
9 anterior segment dysgenesis 4 9.9 FOXC1 PITX2
10 coloboma of macula 9.9 CYP1B1 OPTN
11 glaucoma 1, open angle, a 9.8 CYP1B1 MYOC OPTN
12 excessive tearing 9.8 CYP1B1 MYOC OPTN
13 intestinal atresia 9.8 FOXC1 PITX2
14 optic nerve disease 9.8 MYOC OPTN
15 corneal edema 9.8 CYP1B1 MYOC OPTN
16 primary angle-closure glaucoma 9.8 CYP1B1 MYOC OPTN
17 persistent hyperplastic primary vitreous 9.8 FOXC1 PITX2
18 fuchs' endothelial dystrophy 9.8 PITX2 ZEB1
19 low tension glaucoma 9.7 CDKN2B-AS1 MYOC OPTN WDR36
20 axenfeld-rieger syndrome, type 2 9.7 FOXC1 OPTN PITX2
21 early-onset glaucoma 9.6 CYP1B1 MYOC PITX2
22 axenfeld-rieger syndrome, type 3 9.5 CYP1B1 FOXC1 PITX2
23 anterior segment dysgenesis 9.5 CYP1B1 FOXC1 PITX2
24 glaucoma-related pigment dispersion syndrome 9.5 CYP1B1 LOXL1 PITX2
25 peters-plus syndrome 9.5 CYP1B1 FOXC1 PITX2
26 iris disease 9.4 FOXC1 LOXL1 OPTN PITX2
27 hydrophthalmos 9.3 CYP1B1 FOXC1 OPTN PITX2
28 axenfeld-rieger syndrome 9.3 CYP1B1 FOXC1 OPTN PITX2
29 aniridia 1 9.3 CYP1B1 FOXC1 OPTN PITX2
30 glaucoma 3, primary congenital, a 9.1 CYP1B1 FOXC1 MYOC OPTN PITX2
31 glaucoma, primary open angle 9.1 CDKN2B-AS1 CYP1B1 LOXL1 MYOC OPTN WDR36
32 open-angle glaucoma 9.1 CDKN2B-AS1 CYP1B1 LOXL1 MYOC OPTN WDR36
33 primary congenital glaucoma 8.8 CYP1B1 FOXC1 MYOC OPTN PITX2 WDR36
34 juvenile glaucoma 8.8 CYP1B1 FOXC1 MYOC OPTN PITX2 WDR36
35 adamantinoma of long bones 8.4 CDKN2B-AS1 CYP1B1 FOXC1 MYOC OPTN PITX2

Graphical network of the top 20 diseases related to Intraocular Pressure Quantitative Trait Locus:



Diseases related to Intraocular Pressure Quantitative Trait Locus

Symptoms & Phenotypes for Intraocular Pressure Quantitative Trait Locus

Clinical features from OMIM:

611522

MGI Mouse Phenotypes related to Intraocular Pressure Quantitative Trait Locus:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.5 CYP1B1 FOXC1 LOXL1 OPTN PITX2 WDR36
2 vision/eye MP:0005391 9.02 CYP1B1 FOXC1 MYOC PITX2 ZEB1

Drugs & Therapeutics for Intraocular Pressure Quantitative Trait Locus

PubMedHealth treatment related to Intraocular Pressure Quantitative Trait Locus: 64

Lowering high intraocular pressure can help to delay or stop the gradual progression of vision loss. Glaucoma can't be cured, though, because existing damage to the optic nerve can't be reversed. If someone has glaucoma and high intraocular pressure, it is usually treated using eye drops. Depending on the specific product, the eye drops are applied either once or several times a day.Surgery or laser therapy may be considered if the medication doesn't work, stops working after a while, or is not well tolerated.

Search Clinical Trials , NIH Clinical Center for Intraocular Pressure Quantitative Trait Locus

Genetic Tests for Intraocular Pressure Quantitative Trait Locus

Anatomical Context for Intraocular Pressure Quantitative Trait Locus

MalaCards organs/tissues related to Intraocular Pressure Quantitative Trait Locus:

42
Bone, Eye, Thyroid, Breast, Lung, Brain, Liver
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Intraocular Pressure Quantitative Trait Locus:
# Tissue Anatomical CompartmentCell Relevance
1 Eye Ganglion Cell Layer Mature Ganglion Cells Affected by disease

Publications for Intraocular Pressure Quantitative Trait Locus

Articles related to Intraocular Pressure Quantitative Trait Locus:

(show top 50) (show all 2985)
# Title Authors Year
1
Psychosocial Experiences of Young Adults Diagnosed With Acute Leukemia During Hospitalization for Induction Chemotherapy Treatment. ( 30829935 )
2019
2
Assessing regional left ventricular thickening dysfunction and dyssynchrony via personalized modeling and 3D wall thickness measurements for acute myocardial infarction. ( 30211445 )
2019
3
Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. ( 30755248 )
2019
4
Corrosion Properties of Ultra-Fine-Grained Cu-3 wt%Ti Alloy Fabricated by Combination of Hot Rolling and Aging Treatment. ( 31026982 )
2019
5
Fracture Resistance of Titanium, Zirconia, and Ceramic-Reinforced Polyetheretherketone Implant Abutments Supporting CAD/CAM Monolithic Lithium Disilicate Ceramic Crowns After Aging. ( 30716141 )
2019
6
Phase transition and hardness evolution of a Ti-5Al-5Mo-1Fe-1Cr alloy subjected to isothermal aging. ( 30223177 )
2019
7
The Thioredoxin-Like Family of Selenoproteins: Implications in Aging and Age-Related Degeneration. ( 30229511 )
2019
8
The turricephaly index: A validated method for recording turricephaly and its natural history in Apert syndrome. ( 30683622 )
2019
9
Is early appendectomy in adults diagnosed with acute appendicitis mandatory? A prospective study. ( 30651750 )
2019
10
The Potential Role of Cost and Quality of Life in Treatment Decisions for Arthritis-related Knee Pain for African American and Latina Women. ( 30980467 )
2019
11
Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population. ( 30535993 )
2019
12
Comparison of task interspersal ratios on efficiency of learning and problem behavior for children with autism spectrum disorder. ( 30499101 )
2019
13
Krüppel-Like Factor 1 Gene Mutations in Thalassemia Patients from North Iran: Report of a New Mutation Associated with β-Thalassemia Intermedia. ( 30747024 )
2019
14
Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia. ( 30777047 )
2019
15
Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine. ( 30820323 )
2019
16
Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density. ( 31041514 )
2019
17
A Krüppel-Like Factor 1 Gene Mutation Ameliorates the Severity of β-Thalassemia: A Case Report. ( 31111750 )
2019
18
A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer. ( 31011905 )
2019
19
GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells. ( 30669322 )
2019
20
Complications in staged late titanium cranioplasty and ventriculoperitoneal shunting for traumatic brain injury patients. ( 30995562 )
2019
21
Moderate to severe gambling problems and traumatic brain injury: A population-based study. ( 30832188 )
2019
22
Prognostic role of Amphiregulin and the correlation with androgen receptor in invasive breast cancer. ( 31040043 )
2019
23
Capnography: A support tool for the Detection of Return of Spontaneous Circulation in Out-of-Hospital Cardiac Arrest. ( 31005583 )
2019
24
Advanced airway interventions for paediatric cardiac arrest: A systematic review and meta-analysis. ( 30862528 )
2019
25
Femtosecond laser-assisted cataract surgery for the white cataract. ( 29907631 )
2019
26
Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger. ( 30957594 )
2019
27
Clinical study of chlamydia pneumoniae infection in patients with coronary heart disease. ( 31088358 )
2019
28
Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic Cholangiocarcinoma. ( 31041559 )
2019
29
Are there any solutions for improving the cleft area hygiene in patients with cleft lip and palate? A systematic review. ( 30697916 )
2019
30
Polymethoxylated Flavones Target Cancer Stemness and Improve the Antiproliferative Effect of 5-Fluorouracil in a 3D Cell Model of Colorectal Cancer. ( 30717428 )
2019
31
The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis. ( 30488522 )
2019
32
Abnormal levels of aqueous humor trace elements in patients with cytomegalovirus retinitis. ( 31065104 )
2019
33
Experiences of caregivers of people with dementia in a Korean dementia simulation program. ( 30626192 )
2019
34
Depression after temporal muscle flap: A systematic review of the literature. ( 31056377 )
2019
35
Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review. ( 30920314 )
2019
36
Digital depression screening in HIV primary care in South Africa: mood in retroviral + application monitoring [MIR + IAM]. ( 30854218 )
2019
37
Gender differences in loneliness, anger, depression, self-management ability and biomarkers of chronic illness in chronically ill mid-life adults in Appalachia. ( 30683252 )
2019
38
Dietary patterns during pregnancy derived by reduced-rank regression and their association with gestational diabetes mellitus. ( 30612039 )
2019
39
Pulsed-dye laser as an adjuvant treatment for discoid lupus erythematosus: a randomized, controlled trial. ( 29676592 )
2019
40
IL-10 in vitro could enhance IFNγ expression and suppress PD-1 expression in CD8 T cells from esophageal cancer patients. ( 30951709 )
2019
41
Interplay Between Helicobacter pylori Infection, Interleukin-11, and Leukemia Inhibitory Factor in Gastric Cancer Among Egyptian Patients, by Sabry D, Abdelaleem OO, Hefzy EM, Ibrahim AA, Ahmed TI, Hassan EA, Abdel-Hameed ND, Khalil MAF. J Interferon Cytokine Res 2018;38(11):517-525. DOI: 10.1089/jir.2018.0065. ( 30794008 )
2019
42
Predictors of survival outcome following radical gastrectomy for gastric cancer. ( 30690932 )
2019
43
RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells. ( 30972664 )
2019
44
Oral administration of a new HRI activator as a new strategy to improve High-Fat-Diet-induced glucose intolerance, hepatic steatosis and hypertriglyceridemia through FGF21. ( 30927369 )
2019
45
Headache: an important symptom possibly linked to white matter lesions in thalassaemia. ( 30836423 )
2019
46
Hepatitis C treatment among incarcerated individuals in Canada and strategies to prevent reinfection in the postrelease period. ( 31097483 )
2019
47
Determinants of Hepatitis C Treatment Adherence and Treatment Completion Among Veterans in the Direct Acting Antiviral Era. ( 30903364 )
2019
48
Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting. ( 30653809 )
2019
49
The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science. ( 30623357 )
2019
50
Epigenetics of hepatocellular carcinoma. ( 31056726 )
2019

Variations for Intraocular Pressure Quantitative Trait Locus

ClinVar genetic disease variations for Intraocular Pressure Quantitative Trait Locus:

6 (show top 50) (show all 61)
# Gene Variation Type Significance SNP ID Assembly Location
1 MYOC NM_000261.1(MYOC): c.227G> A (p.Arg76Lys) single nucleotide variant Benign/Likely benign rs2234926 GRCh37 Chromosome 1, 171621525: 171621525
2 MYOC NM_000261.1(MYOC): c.227G> A (p.Arg76Lys) single nucleotide variant Benign/Likely benign rs2234926 GRCh38 Chromosome 1, 171652385: 171652385
3 MYOC NM_000261.1(MYOC): c.855G> T (p.Thr285=) single nucleotide variant Benign/Likely benign rs146606638 GRCh37 Chromosome 1, 171605725: 171605725
4 MYOC NM_000261.1(MYOC): c.855G> T (p.Thr285=) single nucleotide variant Benign/Likely benign rs146606638 GRCh38 Chromosome 1, 171636585: 171636585
5 MYOC NM_000261.1(MYOC): c.823A> T (p.Lys275Ter) single nucleotide variant risk factor rs879255525 GRCh37 Chromosome 1, 171605757: 171605757
6 MYOC NM_000261.1(MYOC): c.823A> T (p.Lys275Ter) single nucleotide variant risk factor rs879255525 GRCh38 Chromosome 1, 171636617: 171636617
7 46;XX;t(X;22)(q13;q13) Translocation Uncertain significance
8 MYOC NM_000261.1(MYOC): c.*241A> G single nucleotide variant Uncertain significance rs186880389 GRCh38 Chromosome 1, 171635684: 171635684
9 MYOC NM_000261.1(MYOC): c.*241A> G single nucleotide variant Uncertain significance rs186880389 GRCh37 Chromosome 1, 171604824: 171604824
10 MYOC NM_000261.1(MYOC): c.*71G> A single nucleotide variant Uncertain significance rs886045564 GRCh38 Chromosome 1, 171635854: 171635854
11 MYOC NM_000261.1(MYOC): c.*71G> A single nucleotide variant Uncertain significance rs886045564 GRCh37 Chromosome 1, 171604994: 171604994
12 MYOC NM_000261.1(MYOC): c.1188G> A (p.Glu396=) single nucleotide variant Likely benign rs61730975 GRCh38 Chromosome 1, 171636252: 171636252
13 MYOC NM_000261.1(MYOC): c.1188G> A (p.Glu396=) single nucleotide variant Likely benign rs61730975 GRCh37 Chromosome 1, 171605392: 171605392
14 MYOC NM_000261.1(MYOC): c.865G> A (p.Asp289Asn) single nucleotide variant Uncertain significance rs767627671 GRCh38 Chromosome 1, 171636575: 171636575
15 MYOC NM_000261.1(MYOC): c.865G> A (p.Asp289Asn) single nucleotide variant Uncertain significance rs767627671 GRCh37 Chromosome 1, 171605715: 171605715
16 MYOC NM_000261.1(MYOC): c.728C> A (p.Thr243Asn) single nucleotide variant Uncertain significance rs781655611 GRCh38 Chromosome 1, 171638599: 171638599
17 MYOC NM_000261.1(MYOC): c.728C> A (p.Thr243Asn) single nucleotide variant Uncertain significance rs781655611 GRCh37 Chromosome 1, 171607739: 171607739
18 MYOC NM_000261.1(MYOC): c.39T> G (p.Pro13=) single nucleotide variant Likely benign rs12082573 GRCh37 Chromosome 1, 171621713: 171621713
19 MYOC NM_000261.1(MYOC): c.39T> G (p.Pro13=) single nucleotide variant Likely benign rs12082573 GRCh38 Chromosome 1, 171652573: 171652573
20 MYOC NM_000261.1(MYOC): c.*182C> A single nucleotide variant Uncertain significance rs886045563 GRCh38 Chromosome 1, 171635743: 171635743
21 MYOC NM_000261.1(MYOC): c.*182C> A single nucleotide variant Uncertain significance rs886045563 GRCh37 Chromosome 1, 171604883: 171604883
22 MYOC NM_000261.1(MYOC): c.1041T> C (p.Tyr347=) single nucleotide variant Benign/Likely benign rs61730974 GRCh38 Chromosome 1, 171636399: 171636399
23 MYOC NM_000261.1(MYOC): c.1041T> C (p.Tyr347=) single nucleotide variant Benign/Likely benign rs61730974 GRCh37 Chromosome 1, 171605539: 171605539
24 MYOC NM_000261.1(MYOC): c.871G> A (p.Val291Ile) single nucleotide variant Uncertain significance rs886045565 GRCh38 Chromosome 1, 171636569: 171636569
25 MYOC NM_000261.1(MYOC): c.871G> A (p.Val291Ile) single nucleotide variant Uncertain significance rs886045565 GRCh37 Chromosome 1, 171605709: 171605709
26 MYOC NM_000261.1(MYOC): c.648G> A (p.Lys216=) single nucleotide variant Uncertain significance rs141584495 GRCh38 Chromosome 1, 171638679: 171638679
27 MYOC NM_000261.1(MYOC): c.648G> A (p.Lys216=) single nucleotide variant Uncertain significance rs141584495 GRCh37 Chromosome 1, 171607819: 171607819
28 MYOC NM_000261.1(MYOC): c.335A> G (p.Glu112Gly) single nucleotide variant Uncertain significance rs886045566 GRCh38 Chromosome 1, 171652277: 171652277
29 MYOC NM_000261.1(MYOC): c.335A> G (p.Glu112Gly) single nucleotide variant Uncertain significance rs886045566 GRCh37 Chromosome 1, 171621417: 171621417
30 MYOC NM_000261.1(MYOC): c.304T> A (p.Leu102Met) single nucleotide variant Uncertain significance rs140017103 GRCh38 Chromosome 1, 171652308: 171652308
31 MYOC NM_000261.1(MYOC): c.304T> A (p.Leu102Met) single nucleotide variant Uncertain significance rs140017103 GRCh37 Chromosome 1, 171621448: 171621448
32 MYOC NM_000261.1(MYOC): c.239C> A (p.Thr80Asn) single nucleotide variant Uncertain significance rs886045567 GRCh38 Chromosome 1, 171652373: 171652373
33 MYOC NM_000261.1(MYOC): c.239C> A (p.Thr80Asn) single nucleotide variant Uncertain significance rs886045567 GRCh37 Chromosome 1, 171621513: 171621513
34 MYOC NM_000261.1(MYOC): c.114G> A (p.Arg38=) single nucleotide variant Uncertain significance rs767644139 GRCh38 Chromosome 1, 171652498: 171652498
35 MYOC NM_000261.1(MYOC): c.114G> A (p.Arg38=) single nucleotide variant Uncertain significance rs767644139 GRCh37 Chromosome 1, 171621638: 171621638
36 MYOC NM_000261.1(MYOC): c.*426C> T single nucleotide variant Uncertain significance rs142425726 GRCh38 Chromosome 1, 171635499: 171635499
37 MYOC NM_000261.1(MYOC): c.*426C> T single nucleotide variant Uncertain significance rs142425726 GRCh37 Chromosome 1, 171604639: 171604639
38 MYOC NM_000261.1(MYOC): c.*331A> G single nucleotide variant Uncertain significance rs548121911 GRCh38 Chromosome 1, 171635594: 171635594
39 MYOC NM_000261.1(MYOC): c.*331A> G single nucleotide variant Uncertain significance rs548121911 GRCh37 Chromosome 1, 171604734: 171604734
40 MYOC NM_000261.1(MYOC): c.*188C> T single nucleotide variant Uncertain significance rs886045562 GRCh38 Chromosome 1, 171635737: 171635737
41 MYOC NM_000261.1(MYOC): c.*188C> T single nucleotide variant Uncertain significance rs886045562 GRCh37 Chromosome 1, 171604877: 171604877
42 MYOC NM_000261.1(MYOC): c.992C> T (p.Ser331Leu) single nucleotide variant Uncertain significance rs775982158 GRCh38 Chromosome 1, 171636448: 171636448
43 MYOC NM_000261.1(MYOC): c.992C> T (p.Ser331Leu) single nucleotide variant Uncertain significance rs775982158 GRCh37 Chromosome 1, 171605588: 171605588
44 MYOC NM_000261.1(MYOC): c.975G> A (p.Thr325=) single nucleotide variant Likely benign rs61730976 GRCh38 Chromosome 1, 171636465: 171636465
45 MYOC NM_000261.1(MYOC): c.975G> A (p.Thr325=) single nucleotide variant Likely benign rs61730976 GRCh37 Chromosome 1, 171605605: 171605605
46 MYOC NM_000261.1(MYOC): c.568G> T (p.Asp190Tyr) single nucleotide variant Uncertain significance rs201930435 GRCh38 Chromosome 1, 171652044: 171652044
47 MYOC NM_000261.1(MYOC): c.568G> T (p.Asp190Tyr) single nucleotide variant Uncertain significance rs201930435 GRCh37 Chromosome 1, 171621184: 171621184
48 MYOC NM_000261.1(MYOC): c.224A> G (p.Gln75Arg) single nucleotide variant Uncertain significance rs886045568 GRCh38 Chromosome 1, 171652388: 171652388
49 MYOC NM_000261.1(MYOC): c.224A> G (p.Gln75Arg) single nucleotide variant Uncertain significance rs886045568 GRCh37 Chromosome 1, 171621528: 171621528
50 MYOC NM_000261.1(MYOC): c.477A> G (p.Leu159=) single nucleotide variant Likely benign rs61730977 GRCh38 Chromosome 1, 171652135: 171652135

Copy number variations for Intraocular Pressure Quantitative Trait Locus from CNVD:

7 (show all 14)
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 38426 10 102495457 102579688 Copy number PAX2 Glaucoma
2 61504 12 1 3100000 Copy number TULP3 Glaucoma
3 69805 12 56300000 66000000 Copy number 12orf56 Glaucoma
4 69807 12 56300000 66000000 Copy number RASSF3 Glaucoma
5 69808 12 56300000 66000000 Copy number TBK1 Glaucoma
6 69809 12 56300000 66000000 Copy number XPOT Glaucoma
7 69812 12 56300000 66000000 Duplication Glaucoma
8 88183 14 87469110 87529660 Deletion GALC Glaucoma
9 101484 16 3862993 3941884 Deletion Glaucoma
10 154919 20 5000000 17800000 Copy number PAK7 Glaucoma
11 192610 5 115200000 121500000 Copy number DMXL1 Glaucoma
12 192611 5 115200000 121500000 Copy number DTWD2 Glaucoma
13 203721 6 1 7100000 Copy number FOXC1 Glaucoma
14 203722 4 111758028 111782566 Copy number PITX2 Glaucoma

Expression for Intraocular Pressure Quantitative Trait Locus

Search GEO for disease gene expression data for Intraocular Pressure Quantitative Trait Locus.

Pathways for Intraocular Pressure Quantitative Trait Locus

Pathways related to Intraocular Pressure Quantitative Trait Locus according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.29 FOXC1 PITX2

GO Terms for Intraocular Pressure Quantitative Trait Locus

Biological processes related to Intraocular Pressure Quantitative Trait Locus according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 camera-type eye development GO:0043010 8.96 FOXC1 PITX2
2 collagen fibril organization GO:0030199 8.62 CYP1B1 FOXC1

Molecular functions related to Intraocular Pressure Quantitative Trait Locus according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transcription factor binding GO:0008134 9.13 FOXC1 PITX2 ZEB1
2 transcription coactivator activity GO:0003713 8.62 FOXC1 ZEB1

Sources for Intraocular Pressure Quantitative Trait Locus

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....